Home › Funds › Bellevue Group AG › ANNX
Bellevue Group AG position in ANNX
ANNEXON INC COM · Health Care
Bellevue Group AG reported holding 4,100,016 shares of ANNX (ANNEXON INC COM) in its Q2 2026 13F filing — a position valued at US$23.4M, representing 0.49% of its reported portfolio and ranking #47 among its reported holdings. Bellevue Group AG has disclosed ANNX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Bellevue Group AG's ANNX position evolved
Bellevue Group AG first disclosed a stake in ANNX in Q1 2024 at 2,182,290 shares (US$15.6M). The position peaked in Q3 2024 at 5,157,290 shares, worth US$30.5M. Across 10 filings, Bellevue Group AG increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 4,100,016 shares valued at US$23.4M — a reduction of -1,057,274 shares quarter over quarter.. Notable position changes include a 136% increase in Q2 2024 (shares rose 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 2.18M | $15.65M | New |
| Q2 2024 | 5.16M | $25.27M | Add |
| Q3 2024 | 5.16M | $30.53M | Hold |
| Q4 2024 | 5.16M | $26.46M | Hold |
| Q1 2025 | 5.16M | $9.95M | Hold |
| Q2 2025 | 5.16M | $12.38M | Hold |
| Q3 2025 | 5.16M | $15.73M | Hold |
| Q4 2025 | 5.16M | $25.89M | Hold |
| Q1 2026 | 5.16M | $28.57M | Hold |
| Q2 2026 | 4.10M | $23.41M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANNX and 13F data
ANNX (ANNEXON INC COM) is a Health Care company. 45 other funds we track also report a position in ANNX — the largest reported positions include Redmile Group, LLC (US$67.8M), BVF INC/IL (US$49.7M), MAK CAPITAL ONE LLC (US$33.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANNX
- Redmile Group, LLC 11.87M sh · $67.78M · Q2 2026
- BVF INC/IL 8.70M sh · $49.67M · Q2 2026
- MAK CAPITAL ONE LLC 5.86M sh · $33.47M · Q2 2026
- Siren, L.L.C. 4.46M sh · $25.46M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 4.44M sh · $25.34M · Q2 2026
- MPM BioImpact LLC 3.54M sh · $20.24M · Q2 2026
- GREAT POINT PARTNERS LLC 3.50M sh · $19.98M · Q2 2026
- Palo Alto Investors LP 2.95M sh · $16.83M · Q2 2026
- Opaleye Management Inc. 1.71M sh · $9.79M · Q2 2026
- Logos Global Management LP 1.50M sh · $8.56M · Q2 2026
- Tetragon Partners GP Ltd 1.24M sh · $7.09M · Q2 2026
- Ishara Investments LP 820.00K sh · $4.68M · Q2 2026
More on Bellevue Group AG
FAQ
How long has Bellevue Group AG held ANNX?
Bellevue Group AG has disclosed ANNX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is Bellevue Group AG's current position in ANNX?
As of Q2 2026, Bellevue Group AG holds 4.10M shares of ANNX (ANNEXON INC COM), valued at $23.41M, representing 0.49% of its reported portfolio and ranking #47.
Has Bellevue Group AG been buying or selling ANNX?
In the latest 13F filing (Q2 2026), Bellevue Group AG reduced its position in ANNX. The position peaked in Q3 2024 at 5.16M shares.
Which other funds hold ANNX?
Other major institutional holders of ANNX include Redmile Group, LLC, BVF INC/IL, MAK CAPITAL ONE LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.